Mossmann et al. have suggested that targeting abnormal ribosome biogenesis by blocking mTORC1/ribosomal protein S6 (RPS6) signaling using drugs is an effective cancer treatment strategy [50]. The gene discussed is RPS6; the disease is cancer.